North American Business Opportunities

Canadian Business
Partnering with Apotex – North America

One in five pharmaceutical prescriptions in Canada is filed with an Apotex product, making us a market share leader in the region.  In the USA, for the products which Apotex competes in, we have +30% market share.

If you are a pharmaceutical company engaged in the following pharmaceutical development programs Apotex aspires to become your Partner of Choice and wants to hear from you.

Early-to-market and limited competition opportunities

  • first-to-file/ race-to-market
  • non-infringing API and/or formulations
  • NCE-1s
  • Currently approved and/or filed products
  • Contract development and/or manufacturing
  • New Technologies

Inhalation

  • Dry Powder Inhalers
  • Metered Dose Inhalers

Injectables

  • Nano particles
  • Carbapenems
  • Depots/ Long Acting injectables
  • Hormones
  • Liposomal
  • Peptides
  • Lyophilized
  • Penicillins
  • Semi-Synthetic Penicillins

Topicals

  • Creams
  • Gels
  • Ointments
  • Lotions

Ophthalmics

  • Ointments and gels

Orals

  • Scheduled products
  • Orodispersable
  • Hormones
  • Buccal/transmucosals
  • Soft and Hard gelatin capsules

Over-the-counter (OTC) products